Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Haleon plc

HLNCFPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$5.03
$0.22(4.57%)
U.S. Market is Open • 14:43

Haleon plc (HLNCF) Stock Overview

Explore Haleon plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap43.1B
P/E Ratio21.57
EPS (TTM)$0.25
ROE0.09%
Fundamental Analysis

AI Price Forecasts

1 Month$4.69
3 Months$6.15
1 Year Target$5.55

HLNCF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Haleon plc (HLNCF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 41.69, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $5.55.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 21.57 and a market capitalization of 43.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.73%
5-Day Change
-4.44%
1-Month Change
-3.68%
3-Month Change
-4.06%
6-Month Change
8.15%
Year-to-Date (YTD) Change
1.15%
1-Year Change
-4.63%
3-Year Change
21.43%
5-Year Change
39.22%
All-Time (Max) Change
39.22%

Contact Information

44 1932 822000
Building 5, Weybridge, NaN, KT13 0NY

Company Facts

245,610 Employees
IPO DateJul 28, 2022
CountryGB
Actively Trading

Frequently Asked Questions